Real-world analysis of afatinib as a first-line treatment for patients with advanced stage non-small-cell lung cancer with uncommon EGFR mutations: a multicenter study in Vietnam.
Ther Adv Med Oncol
; 16: 17588359241242972, 2024.
Article
em En
| MEDLINE
| ID: mdl-38736554
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article